242 related articles for article (PubMed ID: 26061649)
1. Aptamers Selected to Postoperative Lung Adenocarcinoma Detect Circulating Tumor Cells in Human Blood.
Zamay GS; Kolovskaya OS; Zamay TN; Glazyrin YE; Krat AV; Zubkova O; Spivak E; Wehbe M; Gargaun A; Muharemagic D; Komarova M; Grigorieva V; Savchenko A; Modestov AA; Berezovski MV; Zamay AS
Mol Ther; 2015 Sep; 23(9):1486-96. PubMed ID: 26061649
[TBL] [Abstract][Full Text] [Related]
2. Aptamer-Based Methods for Detection of Circulating Tumor Cells and Their Potential for Personalized Diagnostics.
Zamay AS; Zamay GS; Kolovskaya OS; Zamay TN; Berezovski MV
Adv Exp Med Biol; 2017; 994():67-81. PubMed ID: 28560668
[TBL] [Abstract][Full Text] [Related]
3. Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells.
Zhao Z; Xu L; Shi X; Tan W; Fang X; Shangguan D
Analyst; 2009 Sep; 134(9):1808-14. PubMed ID: 19684903
[TBL] [Abstract][Full Text] [Related]
4. Aptamers: Promising Tools for the Detection of Circulating Tumor Cells.
Hassan EM; Willmore WG; DeRosa MC
Nucleic Acid Ther; 2016 Dec; 26(6):335-347. PubMed ID: 27736306
[TBL] [Abstract][Full Text] [Related]
5. Selection of Aptamers Against Vimentin for Isolation and Release of Circulating Tumor Cells Undergoing Epithelial Mesenchymal Transition.
Zheng Y; Zhang J; Huang M; Wang T; Qu X; Wu L; Song J; Wang W; Song Y; Yang C
Anal Chem; 2020 Apr; 92(7):5178-5184. PubMed ID: 32148021
[TBL] [Abstract][Full Text] [Related]
6. Generation of lung adenocarcinoma DNA aptamers for cancer studies.
Jiménez E; Sefah K; López-Colón D; Van Simaeys D; Chen HW; Tockman MS; Tan W
PLoS One; 2012; 7(10):e46222. PubMed ID: 23082117
[TBL] [Abstract][Full Text] [Related]
7. Isolation of DNA aptamers targeting N-cadherin and high-efficiency capture of circulating tumor cells by using dual aptamers.
Gao T; Ding P; Li W; Wang Z; Lin Q; Pei R
Nanoscale; 2020 Nov; 12(44):22574-22585. PubMed ID: 33174555
[TBL] [Abstract][Full Text] [Related]
8. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
[TBL] [Abstract][Full Text] [Related]
9. From ugly duckling to swan: unexpected identification from cell-SELEX of an anti-Annexin A2 aptamer targeting tumors.
Cibiel A; Quang NN; Gombert K; Thézé B; Garofalakis A; Ducongé F
PLoS One; 2014; 9(1):e87002. PubMed ID: 24489826
[TBL] [Abstract][Full Text] [Related]
10. Screening of specific nucleic acid aptamers binding tumor markers in the serum of the lung cancer patients and identification of their activities.
Li K; Xiu CL; Gao LM; Liang HG; Xu SF; Shi M; Li J; Liu ZW
Tumour Biol; 2017 Jul; 39(7):1010428317717123. PubMed ID: 28718373
[TBL] [Abstract][Full Text] [Related]
11. In vitro selections of mammaglobin A and mammaglobin B aptamers for the recognition of circulating breast tumor cells.
Hassan EM; Willmore WG; McKay BC; DeRosa MC
Sci Rep; 2017 Nov; 7(1):14487. PubMed ID: 29101327
[TBL] [Abstract][Full Text] [Related]
12. Newly identified biomarkers for detecting circulating tumor cells in lung adenocarcinoma.
Man Y; Cao J; Jin S; Xu G; Pan B; Shang L; Che D; Yu Q; Yu Y
Tohoku J Exp Med; 2014 Sep; 234(1):29-40. PubMed ID: 25175030
[TBL] [Abstract][Full Text] [Related]
13. Blind SELEX Approach Identifies RNA Aptamers That Regulate EMT and Inhibit Metastasis.
Yoon S; Armstrong B; Habib N; Rossi JJ
Mol Cancer Res; 2017 Jul; 15(7):811-820. PubMed ID: 28396463
[TBL] [Abstract][Full Text] [Related]
14. Selection of DNA aptamers with affinity for pro-gastrin-releasing peptide (proGRP), a tumor marker for small cell lung cancer.
Mie M; Kai T; Le T; Cass AE; Kobatake E
Appl Biochem Biotechnol; 2013 Jan; 169(1):250-5. PubMed ID: 23179274
[TBL] [Abstract][Full Text] [Related]
15. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture.
Song Y; Zhu Z; An Y; Zhang W; Zhang H; Liu D; Yu C; Duan W; Yang CJ
Anal Chem; 2013 Apr; 85(8):4141-9. PubMed ID: 23480100
[TBL] [Abstract][Full Text] [Related]
16. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
[TBL] [Abstract][Full Text] [Related]
17. SELEX aptamer used as a probe to detect circulating tumor cells in peripheral blood of pancreatic cancer patients.
Zhang J; Li S; Liu F; Zhou L; Shao N; Zhao X
PLoS One; 2015; 10(3):e0121920. PubMed ID: 25799539
[TBL] [Abstract][Full Text] [Related]
18. Evidence for circulating cancer stem-like cells and epithelial-mesenchymal transition phenotype in the pleurospheres derived from lung adenocarcinoma using liquid biopsy.
Mirza S; Jain N; Rawal R
Tumour Biol; 2017 Mar; 39(3):1010428317695915. PubMed ID: 28347243
[TBL] [Abstract][Full Text] [Related]
19. Monitoring KRAS mutations in circulating DNA and tumor cells using digital droplet PCR during treatment of KRAS-mutated lung adenocarcinoma.
Guibert N; Pradines A; Farella M; Casanova A; Gouin S; Keller L; Favre G; Mazieres J
Lung Cancer; 2016 Oct; 100():1-4. PubMed ID: 27597273
[TBL] [Abstract][Full Text] [Related]
20. Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma.
Poruk KE; Valero V; Saunders T; Blackford AL; Griffin JF; Poling J; Hruban RH; Anders RA; Herman J; Zheng L; Rasheed ZA; Laheru DA; Ahuja N; Weiss MJ; Cameron JL; Goggins M; Iacobuzio-Donahue CA; Wood LD; Wolfgang CL
Ann Surg; 2016 Dec; 264(6):1073-1081. PubMed ID: 26756760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
